SOBRsafe Inc. (NASDAQ: SOBR) reported third-quarter 2025 revenue growth of 136.1 percent compared to the same period last year, driven primarily by accelerating adoption of the company's SOBRsure GEN 2 alcohol detection device. The technology, which requires no breath, blood, or urine samples, accounted for more than 80 percent of quarterly revenue as the company sold 277 devices during the period.
The company's annual recurring software revenue reached $152.2 thousand, representing a 60.5 percent increase, while gross profit grew to $37.9 thousand. SOBRsafe's marketing refinements contributed to a 266 percent increase in website traffic and the company achieved its highest monthly sales in October, followed by its largest device order in November. These metrics indicate growing market acceptance of the company's passive alcohol detection approach.
SOBRsafe's transdermal technology detects and reports in real-time the presence of alcohol as emitted through a user's skin, providing what the company describes as dignified screening and monitoring solutions for behavioral health, family law and consumer markets. The technology's passive nature represents a significant advancement over traditional alcohol testing methods that require active participation and can be perceived as invasive.
While the company reported a net loss of $2.2 million for the quarter, reflecting increased operating expenses tied to expanded commercial activity, it maintained a cash position of $4.7 million to support ongoing commercialization efforts. SOBRsafe is actively expanding channel partnerships and investing in product development and software capabilities to support long-term growth objectives.
The company's performance suggests increasing market validation for next-generation alcohol detection technologies that enable trust and empower recovery through non-invasive methods. SOBRsafe's backend data platform supports the company's positioning in the behavioral health and monitoring sectors, where passive screening solutions are gaining traction. Additional information about the company is available at https://www.sobrsafe.com.
Industry observers note that the strong demand for SOBRsure GEN 2 devices reflects broader market trends toward more dignified approaches to alcohol monitoring in various professional and personal contexts. The technology's application across multiple markets including behavioral health and family law indicates potential for continued expansion as awareness grows about alternatives to traditional testing methods.
